Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

SARS-CoV-2 Tied to Higher Respiratory Failure Risk Than Flu

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

Busy? More Time-Saving Tips Won’t Help, but This Will

The clock isn’t going to slow down. The system isn’t going to fix itself. Here’s how clinicians are finding a way to live — and work — inside that reality.

Burden of ED Urologic Care Increases in Ontario

Emergency department visits and admissions for urology conditions surged in Ontario from 2007 to 2022, with longer wait times, especially for women and patients with low income.

Cost-Related Delay in Care Tied to Higher ED Use

Delaying or forgoing care for cost-related reasons is linked to increased odds of emergency department visits among Latino adults, highlighting the need to reduce financial barriers to timely care.

Physician Attire and Trust: How Much Does It Matter?

Physicians’ clothing influences how patients judge competence and approachability, with preferences varying by care setting and specialty and shaping clinical interactions.

‘Dancing’ Molecules Spur Healing in Spinal Cord Tissue

Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was surprising and illuminating.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

The clock isn’t going to slow down. The system isn’t going to fix itself. Here’s how clinicians are finding a way to live — and work — inside that reality.

Emergency department visits and admissions for urology conditions surged in Ontario from 2007 to 2022, with longer wait times, especially for women and patients with low income.

Delaying or forgoing care for cost-related reasons is linked to increased odds of emergency department visits among Latino adults, highlighting the need to reduce financial barriers to timely care.

Physicians’ clothing influences how patients judge competence and approachability, with preferences varying by care setting and specialty and shaping clinical interactions.

Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was surprising and illuminating.

News All Time

Torque Teno Virus Predicts Malignancy Post-Kidney Transplant

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

NICE Backs Belantamab Mafodotin for Relapsed Myeloma

NICE has recommended belantamab mafodotin for relapsed multiple myeloma, with trial data showing remissions of more than 3 years.

Study Identifies Novel Stress-Inflammation Pathway in AD

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

Scotland Backs New Immunotherapy in Advanced Cervical Cancer

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Eye Shingles Tied to Cancer Risk in Those With Immune Issues

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

SLIT Adherence May Lower Rhinitis Severity in Children

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

Schistosomiasis: Four Things You May Not Know

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

C auris Is Now Endemic in Europe. Can It Be Contained?

The fungus, identified only 20 years ago, is endemic in healthcare facilities of five European countries. What can be done to stop its spread?

New Pulmonary Embolism Clinical Categories PCPs Should Know

Dr Nina Lum discusses key takeaways of new PE clinical categories for primary care physicians and providers.

Amgen's Lung Cancer Drug Tarlatamab Wins China Approval

Amgen's lung cancer drug tarlatamab has won ⁠approval from China's National Medical Products Administration.

US FDA Expands Approval for Travere's Drug for Rare Kidney Disease

The U.S. Food and Drug Administration has approved the expanded use of Travere Therapeutics' ⁠drug to treat a rare kidney disorder, the company said on Monday.

EPP and XLP: Dersimelagon Delays Photodermatoses Prodrome

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.

Preparing for the Next Pandemic: What the EU Wants

The EU aims to offer pharmaceutical companies ‘workable terms’ in policies designed to improve future pandemic response.

Pemphigus: Rituximab Shows Lower Cancer Risk Than Other Txs

Rituximab is linked to a lower 5-year risk for new cancer than mycophenolate mofetil or azathioprine in patients with pemphigus, study shows.

Gastritis Study Reveals Antibody-Anemia Connection

Anemia is common in patients with autoimmune gastritis and is associated with positivity for anti-intrinsic factor antibodies.

Recommended News For You

Analysis of projected cancer rates in Canada by 2024.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

Recommended Articles For You

Understanding the Importance of CA125: A Comprehensive Guide  

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025 

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology 

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

2.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

3.

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

Mapping lifelong chronic health risks for childhood cancer survivors

1.

Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care

2.

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies 

3.

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances

4.

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity

5.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot